IRIS

Perfluorohexanesulfonic Acid (PFHxS)

CASRN 355-46-4 | DTXSID7040150

Noncancer Assessment

Reference Dose for Oral Exposure (RfD) (PDF) (6 pp, 413 K) Last Updated:

System RfD (mg/kg-day) Basis PoD Composite UF Confidence
Developmental, Immune 4 x 10 -10
(Chronic)
Decreased serum anti-tetanus antibody concentration in children at age 7 yrs (Grandjean et al., 2012; Budtz-Jorgensen and Grandjean, 2018) BMDL (HED): 1.16 x 10-8
mg/kg-day
30
MF: None
Medium

 


System RfC (mg/m3) Basis PoD Composite UF Confidence

 

Cancer Assessment

WOE Characterization Framework for WOE Characterization
Not available.
Basis:

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (6 pp, 413 K)

Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (6 pp, 413 K)

Not assessed under the IRIS Program.

Organ/System-Specific RfDs

System RfD (mg/kg-day) Basis PoD UF Confidence Notes
Developmental, Immune 4 x 10-10
(Chronic)
Decreased serum anti-tetanus antibody concentration in children at age 7 yrs (Grandjean et al., 2012; Budtz-Jorgensen and Grandjean, 2018) BMDL (HED): 1.16 x 10-8
mg/kg-day
30 Medium
Endocrine 2 x 10-7
(Chronic)
Decreasedserum total T4 levels in F1 Wistar rats (Ramhoj et al., 2018) NOAEL (HED): 2.45 x 10-5
mg/kg-day
100 Medium
Developmental, Immune 4 x 10-10
(Subchronic)
Decreased serum anti-tetanus antibody concentration in children at age 7 yrs (Grandjean et al., 2012; Budtz-Jorgensen and Grandjean, 2018) BMDL (HED): 1.16 x 10-8
mg/kg-day
30 Medium
Endocrine 2 x 10-7
(Subchronic)
Decreased serum total T4 levels in F1 Wistar rats (Ramhoj et al., 2018) NOAEL (HED): 2.45 x 10-5
mg/kg-day
100 Medium

 

Additional EPA toxicity information may be available by visiting the following sites:

You will need Adobe Reader to view some of the files on this page. See EPA's PDF page to learn more.

Contact Us to ask a question, provide feedback or report a problem.